These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32652651)

  • 1. A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma.
    Weiss TLD; Furtado CM; Antunes MV; Gössling G; Schwartsmann G; Linden R; Verza SG
    Biomed Chromatogr; 2020 Nov; 34(11):e4947. PubMed ID: 32652651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivatives.
    Caron P; Turcotte V; Lévesque E; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1104():249-255. PubMed ID: 30537624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An LC-MS/MS method for quantification of the active abiraterone metabolite Δ(4)-abiraterone (D4A) in human plasma.
    van Nuland M; Rosing H; de Vries J; Ovaa H; Schellens JHM; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Nov; 1068-1069():119-124. PubMed ID: 29059586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients.
    Bhatnagar A; McKay MJ; Thaysen-Andersen M; Arasaratnam M; Crumbaker M; Gurney H; Molloy MP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121741. PubMed ID: 31421381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients.
    Dillenburg Weiss TL; Gössling G; Venzon Antunes M; Schwartsmann G; Linden R; Gasparin Verza S
    J Pharm Biomed Anal; 2021 Feb; 195():113861. PubMed ID: 33373824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry.
    Bhatnagar A; McKay MJ; Crumbaker M; Ahire K; Karuso P; Gurney H; Molloy MP
    J Pharm Biomed Anal; 2018 May; 154():66-74. PubMed ID: 29533860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an LC-MS/MS Method for the Simultaneous Quantification of Abiraterone, Enzalutamide, and Their Major Metabolites in Human Plasma.
    van Nuland M; Hillebrand MJX; Rosing H; Schellens JHM; Beijnen JH
    Ther Drug Monit; 2017 Jun; 39(3):243-251. PubMed ID: 28490047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating bioanalytical capabilities of paper spray ionization for abiraterone drug quantification in patient plasma.
    Bhatnagar A; McKay MJ; Arasaratnam M; Crumbaker M; Gurney H; Molloy MP
    J Mass Spectrom; 2020 Oct; 55(10):e4584. PubMed ID: 32725840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical challenges in quantifying abiraterone with LC-MS/MS in human plasma.
    Benoist GE; van der Meulen E; Lubberman FJE; Gerritsen WR; Smilde TJ; Schalken JA; Beumer JH; Burger DM; van Erp NP
    Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28370076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel LC-MS/MS method for simultaneous determination of abiraterone and its seven steroidal metabolites in human serum: Innovation in separation of diastereoisomers without use of a chiral column.
    Alyamani M; Li Z; Upadhyay SK; Anderson DJ; Auchus RJ; Sharifi N
    J Steroid Biochem Mol Biol; 2017 Sep; 172():231-239. PubMed ID: 27063554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of an UPLC-MS/MS method for the therapeutic drug monitoring of oral anti-hormonal drugs in oncology.
    van Nuland M; Venekamp N; de Vries N; de Jong KAM; Rosing H; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Feb; 1106-1107():26-34. PubMed ID: 30639947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of acamprosate in human plasma by UPLC-MS/MS: Application to therapeutic drug monitoring.
    Ozdemir M; Kul A; Ozilhan S; Sagirli O
    Biomed Chromatogr; 2020 Nov; 34(11):e4936. PubMed ID: 32602563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer.
    Arasaratnam M; Crumbaker M; Bhatnagar A; McKay MJ; Molloy MP; Gurney H
    Cancer Chemother Pharmacol; 2019 Jul; 84(1):139-146. PubMed ID: 31081533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A HPLC-fluorescence method for the quantification of abiraterone in plasma from patients with metastatic castration-resistant prostate cancer.
    Belleville T; Noé G; Huillard O; Thomas-Schoemann A; Vidal M; Goldwasser F; Alexandre J; Blanchet B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():86-90. PubMed ID: 25813901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a high throughput bioanalytical UPLC-MS/MS method for simultaneous determination of tamoxifen and sulphoraphane in rat plasma: Application to an oral pharmacokinetic study.
    Mangla B; Alam O; Rub RA; Iqbal M; Singh A; Patel KS; Kohli K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122260. PubMed ID: 32679526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors.
    Bruin MAC; de Vries N; Lucas L; Rosing H; Huitema ADR; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121925. PubMed ID: 31915109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Rapid Dilute-and-Shoot UPLC-MS/MS Assay to Simultaneously Measure 37 Drugs and Related Metabolites in Human Urine for Use in Clinical Pain Management.
    Dahlin JL; Palte MJ; LaMacchia J; Petrides AK
    J Appl Lab Med; 2019 May; 3(6):974-992. PubMed ID: 31639689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
    Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple and fast UPLC-MS method for quantifying the anti-inflammatory candidate 5'-methoxynobiletin in rat plasma: Validation and application in a preliminary pharmacokinetic study.
    Faqueti LG; da Silva LAL; Moreira GSG; Honorato LA; Dos Santos ARS; Dalla Costa T; Biavatti MW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1158():122387. PubMed ID: 33091674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of fascaplysin in rat plasma with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS): application to a pharmacokinetic study.
    Hu Z; Zhang M; He M; Fang B; Bao X; Yan X; Liang H; Wang H
    J Pharm Biomed Anal; 2019 Jul; 171():126-131. PubMed ID: 30986762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.